Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Mariel Metcalfe
  • September 20, 2019
  • Articles

Living with Atopic Dermatitis: Effects beyond the skin’s surface

Living with Atopic Dermatitis: Effects beyond the skin’s surface

Head of Living With, Mariel Metcalfe, discusses the nature of Atopic Dermatitis and some key findings from a recent study conducted in Europe

Earlier this year, we published the report “Living with Atopic Dermatitis (AD) EU”, based on primary market research, which reveals key insights and unmet needs from the AD adult and paediatric patient perspective and treatment journey. In December 2017, we published a US report, which is also available to purchase.

read more »

  • Posted by Harrison Gaiger
  • September 20, 2019
  • Articles

Engaging patient advocacy groups: The key to conducting effective rare disease research

Engaging patient advocacy groups: The key to conducting effective rare disease research

This article, published by Pharma Times September 2019, outlines why market researchers should reach out to patient advocacy groups when conducting rare disease research.

Until recently, the size of the market for specific rare diseases had made it difficult for pharmaceutical companies to justify research and development costs. The introduction of regulatory benefits such as longer market exclusivity, breakthrough designations, reduced fees and tax incentives have encouraged more investment. Nevertheless, where funding has been allocated for rare diseases, the scarcity and geographical dispersal of patients can make it difficult to conduct effective market research. Identifying and recruiting respondents is one of the core challenges when conducting research in this space.

read more »

  • Posted by Paul Reed
  • September 10, 2019
  • Articles

The digital patient

The digital patient

Comparing usage and attitudes in mature and emerging markets

We may talk about always putting the patient at the heart of healthcare, but in some less established world markets, is this feasible? The rise of chronic diseases in some regions, combined with an ageing and growing population, is putting unbearable pressure on health-care systems already at capacity. 

read more »

  • Posted by Harrison Gaiger
  • August 20, 2019
  • Articles

Game changer: The role of immersive technologies in the healthcare and pharmaceutical industries

Game changer: The role of immersive technologies in the healthcare and pharmaceutical industries

This article, published by Med Ad News August 2019, explores how technological advances in VR/AR are offering new opportunities for conducting healthcare market research.

The next decade promises to be an exciting time for science and innovation. Technological advancements are being made on a daily basis and many of these have the potential to directly impact our everyday lives. In fact, technology is changing at such a rate that it can often seem difficult to keep up. One advancement with the potential to change how we interact with the world is Virtual and Augmented Reality (VR/AR). Since the launch of top-end devices such as the Oculus Rift headset and many simpler, more affordable designs such as the Google Cardboard, interest in VR/AR has sky-rocketed. Coupled with advancements in smartphone technology it is now possible for larger numbers of people to experience VR/AR.

read more »

  • Posted by Misti Paul and Helen Ansell
  • August 7, 2019
  • Articles

Integrating data

Integrating data

How to conduct an effective epidemiological data review

Clients often ask us if we can triangulate various data sources to fully understand the opportunity for an asset. There are clear benefits - combining primary market research findings with existing data sets provides validity and depth, whilst eliminating many inconsistencies, which helps guide the direction for future marketing strategy and initiatives. 

read more »